Syros Pharmaceuticals said it plans to wind down its operations, according to a Securities and Exchange Commission filing. The Cambridge, Mass., company said it would proceed with a voluntary ...

Syros Pharmaceuticals (SYRS) announced that its Board of Directors has approved and the company intends to proceed with the voluntary delisting ...

EST Syros Pharmaceuticals (SYRS) trading halted, news pendingDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

While model-year updates and special editions made up most of the launches, premium brands brought in a few fresh models as ...

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) has been given a consensus rating of “Hold” by the five research ...

Syros gets two engine options – a 1.0-litre, 3-cylinder, turbo-petrol which puts out 120hp of power and 172Nm torque. It ...

Looking to buy an urban family diesel car under Rs 15 lakh? Here’s why the Kia Syros should be on top of your list.

Discover the top 5 cars equipped with ADAS Level 2 technology, offering enhanced safety and convenience features. From Kia ...

Kia has already seen over 20,000 interested buyers who have booked themselves brand-new Syros! Here is a look at the premium ...

The Kia Syros is the latest addition to the lineup of cars in India and comes at a starting price of Rs 9 lakh (ex-showroom).

Beta Film and Athens-based Foss Productions are teaming up for a six-hour drama series, “The Great Chimera,” that will bring ...

Syros Pharmaceuticals, which said in November it would cut most of its workforce, said on Friday it will wind down operations. The company's stock dropped 45% to 8 cents in after-hours trading.